Review
Copyright ©The Author(s) 2018.
World J Gastroenterol. Dec 7, 2018; 24(45): 5063-5075
Published online Dec 7, 2018. doi: 10.3748/wjg.v24.i45.5063
Table 1 Comparison of experimental models of alcoholic liver disease
ModelsAnimal modelCharacteristicsAdvantages and disadvantages
Lieber-DeCarli liquid diet[27,28]Rat/miceChronic ethanol feeding (4-12 wk)Easy to perform
Marked elevation of ALT
Short term feeding with no mortality rate
No liver fibrosis
Rat/miceChronic ethanol feeding + single/multiple binges (4-6 wk)Easy to perform
Marked elevation of ALT and marked steatosis
Long term feeding + multiple binges with a high mortality rate
No liver fibrosis
Rat/mice+ Second hit: DEN, LPS, CCl4, APAP (4-12 wk)Easy to perform
Marked elevation of ALT and marked steatosis
Long term feeding + multiple binges + injection with a high mortality rate
Liver fibrosis
Ethanol ad libitum feeding[27,28]MiceOral alcohol in drinking water (10 d/1-2 wk)Easy to perform
Minimal elevation of ALT and mild steatosis
Short-or long-term feeding with no mortality rate
No liver fibrosis
The Tsukamoto-French model[27,28]Rat/miceIntragastric infusion (2-3 mo)Difficult to perform
Requirement for intensive medical care
Marked elevation of ALT and steatosis
Long-term feeding with a high mortality rate
Mild liver fibrosis
The NIAA model[47]MiceLDE + single ethanol bingeCost and time efficient
High blood alcohol levels
Liver injury
Inflammation
Fatty liver
Rat /miceLDE + 3 ethanol bingesCost and time efficient
Increased blood alcohol levels
Augmented liver injury
Increases in ERK1/2
Ethanol + CCl4 treatment[106]Mice4% ethanol liquid diet + 2 times IP CCl4 injection per week (8 wk)Easy to perform
Toxic components
Elevated acetaldehyde levels
Liver fibrosis